Neuraptive Therapeutics

Neuraptive Therapeutics Overview

  • Founded
  • 2016
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $11.5M
Latest Deal Amount
  • Investors
  • 2

Neuraptive Therapeutics General Information


Developer of a therapeutic technology designed to facilitate surgical repair of injured peripheral nerves. The company's nerve repair system AxoFuse induces the fusion of severed axons which immediately restores electrophysiological activity that prevents natural nerve degeneration and is directed specifically to improve clinical outcomes for the patients, enabling patients to rapidly recover their damaged peripheral nerves injuries and also reduce their pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 2697 Trailridge Drive West
  • CO 80026
  • United States
+1 (303) 000-0000

Neuraptive Therapeutics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuraptive Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Corporate (Series A) 19-Dec-2018 $11.5M 000.00 Completed Startup
2. Angel (individual) 15-Aug-2018 00000 00.00 Completed Startup
1. Angel (individual) 06-Sep-2017 $1M $1M Completed Startup

Neuraptive Therapeutics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
000000 Corporation Alachua, FL 000 0000 00000000 0000

Neuraptive Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Carter Freeman Chief Financial Officer
Stefan Proniuk Ph.D Chief Development Officer
David Jackson Ph.D Founder & Board Member
Robert Radie Chief Executive Officer & Chairman

1 Former Executive

Neuraptive Therapeutics Board Members (4)

Name Representing Role Since
David Jackson Ph.D Neuraptive Therapeutics Founder & Board Member 000 0000
Gino Di Sciullo Ph.D Self Board Member 000 0000
John Paulos Ph.D Central Texas Angel Network Board Member 000 0000
Robert Radie Self Chief Executive Officer & Chairman 000 0000

Neuraptive Therapeutics Investors (2)

To view Neuraptive Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Central Texas Angel Network Angel Group Minority 000 0000 000000 0
New Rhein Healthcare Growth/Expansion Minority 000 0000 000000 0

Ready to get started?

Request a free trial